Literature DB >> 22994719

Some epidemiological measures of cancer in Kuwait: national cancer registry data from 2000-2009.

A El-Basmy1, S Al-Mohannadi, A Al-Awadi.   

Abstract

INTRODUCTION: Cancer is the second cause of death in Kuwaiti people after cardiovascular diseases. This study is the first in the country to describe epidemiological measures related to cancer in this population.
METHODS: Data obtained from the Kuwait cancer registry included all Kuwaiti patients between years 2000-2009. Analyses were conducted using age-specific rates, the age-standardization-direct method, 95% confidence intervals (95% CI), cumulative risk by the age of 74 years, limited-duration prevalence, mortality and forecasting to year 2029.
RESULTS: It was noted that the commonest cancer sites were colorectal with an age standardized incidence rate (ASIR) of 16.1/100,000 in males and breast (49.4/100,000) in the female population. The trend of cancer incidence (1974-2009) showed no statistically significant change. First causes of death due to cancer were female breast 8(6.4-9.6)/100,000 and lung (males) 8.1/100,000 (6.6-10.0). The risk of developing cancer by the age of 74 was 13.4% (1/8) and 14.3% (1/7) in males and females respectively, and the risk of dying from cancer in the same age group was 1/17 and 1/23. By the end of 2009, prevalent cases represented 0.52% of the Kuwaiti population. In the year 2029, the total number of cancer cases is expected to reach 1200 cases compared to 889 cases in 2009. CONCLUSIONS AND RECOMMENDATIONS: The most common cancers in Kuwait (breast, colorectal and lung) are largely preventable. Prompt and effective interventional prevention programs that vigorously involve diet, anti-smoking and physical activity for both sexes are urgently required.

Entities:  

Mesh:

Year:  2012        PMID: 22994719     DOI: 10.7314/apjcp.2012.13.7.3113

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  5 in total

1.  Molecular spectrum of KRAS, NRAS, BRAF, PIK3CA, TP53, and APC somatic gene mutations in Arab patients with colorectal cancer: determination of frequency and distribution pattern.

Authors:  Humaid O Al-Shamsi; Jeremy Jones; Yazan Fahmawi; Ibrahim Dahbour; Aziz Tabash; Reham Abdel-Wahab; Ahmed O S Abousamra; Kenna R Shaw; Lianchun Xiao; Manal M Hassan; Benjamin R Kipp; Scott Kopetz; Amr S Soliman; Robert R McWilliams; Robert A Wolff
Journal:  J Gastrointest Oncol       Date:  2016-12

Review 2.  Association between the NBS1 Glu185Gln polymorphism and lung cancer risk: a systemic review and meta-analysis.

Authors:  Lixin Wang; Jinsong Cheng; Jinyu Gao; Jipeng Wang; Xiaoning Liu; Liwen Xiong
Journal:  Mol Biol Rep       Date:  2012-12-29       Impact factor: 2.316

3.  Histopathological and epidemiological findings of colonoscopy screening in a population with an average risk of colorectal cancer in Kuwait.

Authors:  Hassan B Abdelnaby; Ali A Abuhussein; Ahmed M Fouad; Wafaa A Alhashash; Abdulrahman S Aldousari; Ahmed M Abdelaleem; Marcus Edelhamre; Maha H Shahin; Mohammed Faisal
Journal:  Saudi J Gastroenterol       Date:  2021 May-Jun       Impact factor: 2.485

4.  Growth inhibitory and chemo-sensitization effects of naringenin, a natural flavanone purified from Thymus vulgaris, on human breast and colorectal cancer.

Authors:  Mohamed Salah I Abaza; Khaled Y Orabi; Ebtehal Al-Quattan; Raja'a J Al-Attiyah
Journal:  Cancer Cell Int       Date:  2015-04-24       Impact factor: 5.722

5.  NBN Gene Polymorphisms and Cancer Susceptibility: A Systemic Review.

Authors:  Francesco Berardinelli; Alessandra di Masi; Antonio Antoccia
Journal:  Curr Genomics       Date:  2013-11       Impact factor: 2.236

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.